Harvey Berger Net Worth & Insider Trades

Harvey Berger - Chairman & CEO, Ariad Pharmaceuticals Inc

As of January 5, 2016

What is Harvey Berger's Net Worth?

The current estimated net worth of Ariad Pharmaceuticals Inc's Chairman & CEO, Harvey Berger, is estimated to be about $10.83M . Harvey Berger owns about 2,109,537 units of Ariad Pharmaceuticals Inc common stock. In the last year at Ariad Pharmaceuticals Inc, Harvey Berger has sold an estimated value of $2.96M worth.

What is Harvey Berger's Past Insider Trading?

Harvey Berger's largest purchase order was 25,000 units , worth over $170.85K on February 13, 2015. In total, Harvey Berger has made about 9 transactions over a year of their time at Ariad Pharmaceuticals Inc. Harvey Berger usually trades in February, January and March, with the busiest year in 2015.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What are Ariad Pharmaceuticals Inc's Past Insider Trades?

Ariad Pharmaceuticals Inc's most recent insider trade came on January 10, 2017 by Daniel Bollag who sold 32,000 units worth $760.96K . In the last 2 years, insiders at Ariad Pharmaceuticals Inc have sold an estimated value of $16.96M and bought an estimated value of $5.06M worth of shares. Insider trading is most common in February, with the busiest year in 2016. The most active traders at the company are Timothy Clackson, President,  Daniel Bollag, Sr. VP,  and Maria Cantor, SVP .

ARIAD PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1